Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Clinical Risk Grouping Solution Market

Clinical Risk Grouping Solution Market Trends

Report ID: GMI9982
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Clinical Risk Grouping Solution Market Trends

The increase in adoption of electronic health records (EHR) system at healthcare facilities such as hospitals, clinics, and ambulatory care centers, has been a key driver for clinical risk grouping solution industry. Also, innovations in data analytics, artificial intelligence, and machine learning enhance the capabilities of clinical risk grouping solutions such as EHRs software. These advancements enable more accurate risk prediction and better patient management.

For instance, in March 2024, Health Information Management Systems (HiMS) launched AxiomEHR, an all-new, AI-powered electronic health record (EHR) solution that supports data-based decision-making, flexible care coordination, and overall resilience to drive quality-based care. Thus, technological advancements in clinical risk grouping solution and the growing reliance on data-driven decision-making in healthcare for improving clinical outcomes and operational efficiency will boost the market for clinical risk grouping solution.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical risk grouping solution industry size was worth USD 673.4 million in 2023 and is projected to expand at 11.5% CAGR from 2024 to 2032, owing to the rise in prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer.

The software component segment in the clinical risk grouping solution industry accounted for USD 526.1 million in 2023 due to its ability to be customized according to the specific needs of different healthcare providers.

The population health management segment in the clinical risk grouping solution industry accumulated 33.2% market share in 2023 and is estimated to depict substantial growth between 2024 and 2032, due to the growing prevalence of chronic diseases.

North America clinical risk grouping solution industry accounted for 45.2% market share in 2023 and is projected to witness substantial gains from 2024 to 2032, led by the presence of strong technological structure with continuous innovation in healthcare.